Breaking News

Bespak Completes First Life Cycle Assessment for pMDI Valve

The project was undertaken to better understand the carbon impact of Bespak’s materials and manufacturing processes.

Author Image

By: Charlie Sternberg

Associate Editor

Bespak, a specialist inhalation contract development and manufacturing organization (CDMO), has completed its first life cycle assessment (LCA) for its BK357 pressurized Metered Dose Inhaler (pMDI) valve. The completion of Bespak’s first LCA marks a significant milestone that has been achieved as part of Bespak’s overarching sustainability strategy. It follows Bespak’s investment in manufacturing capabilities at clinical and commercial scale for low carbon pMDIs incorporating the low GWP prop...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters